Inventiva SA IVA:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EST
15.45quote price arrow down-0.30 (-1.90%)
Volume
5,279
52 week range
9.01 - 19.06

...

Loading . . .

KEY STATS

  • Open15.50
  • Day High15.60
  • Day Low15.27
  • Prev Close15.75
  • 52 Week High19.06
  • 52 Week High Date01/21/21
  • 52 Week Low9.01
  • 52 Week Low Date07/14/20
  • Market Cap478.15M
  • Shares Out30.91M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Inventiva SA News

There is no recent news for this security.

Latest IVA News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Inventiva SA is a France-based company engaged in the biotechnology sector. The Company focuses on the development of therapies in the area of oncology, fibrosis and rare diseases. The Company’s pipeline comprises a number of development programs, such as Clinical Pipeline, Preclinical Pipeline, AbbVie Collaboration and Boehringer-Ingelheim collaboration. Its drug candidates target at the treatment of non-alcoholic steatohepatitis (NASH), systemic sclerosis (SSc), various...
Frederic Cren
Chief Executive Officer
Jean Volatier
Chief Financial Officer
Nicolas Gueugnon
General Counsel
David Nikodem Ph.D.
Vice President
Jerome Bernard Ph.D.
Vice President
Address
50 rue de Dijon, Daix
Daix
21121
France